Predictive Factors in Response to Inhaled Corticoids in Chronic Cough
NCT02715167 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2016-03-22
Summary
The hypothesis is that a high fractional exhaled nitric oxide can predict the response to inhaled corticoids in chronic cough.
Conditions
- Healthy
Interventions
- DRUG
-
Budesonide novolizer
- DRUG
Sponsors & Collaborators
-
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2016-04-30
- Completion
- 2017-12-31
More Related Trials
-
The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms
NCT02294279 ·Status: COMPLETED ·Phase: PHASE4
-
Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients
NCT01113853 ·Status: COMPLETED
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough
NCT02655562 ·Status: SUSPENDED ·Phase: PHASE4
-
Airway Inflammation and Disease Burden in Asthmatic Smokers
NCT02833727 ·Status: UNKNOWN
-
The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry
NCT00402207 ·Status: COMPLETED ·Phase: NA
-
The Effects of Montelukast on Smokers With Asthma
NCT00712335 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
NCT06433921 ·Status: RECRUITING ·Phase: PHASE1
-
Exhaled Nitric Oxide and Nasal Lavage Fluid
NCT00773578 ·Status: COMPLETED
-
Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients
NCT01577082 ·Status: COMPLETED ·Phase: PHASE3
-
Bronchodilating and Bronchoprotective Effects of Deep Inspirations
NCT01659476 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test
NCT05634473 ·Status: UNKNOWN ·Phase: NA
-
Determining the Optimal Adenosine Provocation Test
NCT01610921 ·Status: COMPLETED ·Phase: NA
-
Monitoring Asthma Treatment Using Exhaled Nitric Oxide
NCT00562991 ·Status: COMPLETED
-
Predicting Steroid Response Using Exhaled Nitric Oxide
NCT01308411 ·Status: COMPLETED ·Phase: NA
-
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
NCT00522782 ·Status: COMPLETED ·Phase: PHASE4
-
Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma
NCT04203472 ·Status: COMPLETED ·Phase: NA
-
Exhaled Nitric Oxide and Airway Caliber in Children With Asthma
NCT01645397 ·Status: COMPLETED
-
Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough
NCT02303600 ·Status: UNKNOWN ·Phase: NA
-
U-LABA/ICS Effects on Exercise Performance, Indacaterol
NCT06067100 ·Status: RECRUITING ·Phase: NA
-
Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma
NCT04167280 ·Status: COMPLETED ·Phase: PHASE4
-
The Potential Added Value of Impulse Oscillometry in Asthma Monitoring
NCT06425562 ·Status: RECRUITING ·Phase: NA
-
Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)
NCT00421018 ·Status: COMPLETED ·Phase: NA
-
PreAsthmaControl (PAC)
NCT00234390 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma
NCT00862264 ·Status: COMPLETED ·Phase: PHASE3